Free Trial

Belite Bio (BLTE) Institutional Ownership

Belite Bio logo
$55.75 +1.39 (+2.56%)
As of 11:06 AM Eastern

Institutional Ownership Changes (13F Filings) for Belite Bio (NASDAQ:BLTE)

Current
Institutional Ownership
Percentage
0.53%
Number of
Institutional Buyers
(last 12 months)
6
Total
Institutional Inflows
(last 12 months)
$9.45M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$181.17K
Get BLTE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Belite Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

BLTE Institutional Buying and Selling by Quarter

Belite Bio Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
1/3/2025 GAMMA Investing LLC1,290$81K0.0%+48.1%0.004%
12/26/2024JPMorgan Chase & Co.6,356$298K0.0%+7,122.7%0.021%
11/15/2024XTX Topco Ltd5,394$253K0.0%N/A0.018%
11/15/2024State Street Corp20,086$942K0.0%+28.2%0.066%
11/15/2024Point72 Asset Management L.P.4,800$225K0.0%-34.3%0.016%
10/7/2024 GAMMA Investing LLC871$41K0.0%+103.5%0.003%
8/19/2024Point72 Asset Management L.P.7,311$334K0.0%-16.0%0.025%
8/15/2024Armistice Capital LLC148,000$6.76M0.1%N/A0.497%
2/13/2024Armistice Capital LLC36,000$1.65M0.0%N/A0.130%
2/7/2024Jump Financial LLC5,200$238K0.0%N/A0.019%
11/8/2023Atria Wealth Solutions Inc.74,019$2.36M0.0%-90.9%0.272%
8/3/2023Atria Wealth Solutions Inc.814,498$11.64M0.2%+0.3%3.268%
2/13/2023Atria Wealth Solutions Inc.811,765$24.47M0.4%+1,397.6%3.264%
11/3/2022Barclays PLC6,661$223K0.0%N/A0.027%
8/15/2022Atria Wealth Solutions Inc.49,463$1.54M0.0%N/A0.199%
(Data available from 1/1/2016 forward)

BLTE Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of BLTE shares?

During the previous two years, the following institutional investors and hedge funds held shares of Belite Bio shares: Armistice Capital LLC ($6.76M), Atria Wealth Solutions Inc. ($2.36M), State Street Corp ($942K), JPMorgan Chase & Co. ($298K), XTX Topco Ltd ($253K), Jump Financial LLC ($238K), and Point72 Asset Management L.P. ($225K).Learn more on BLTE's institutional investors.

What percentage of Belite Bio stock is owned by institutional investors?

0.53% of Belite Bio stock is owned by institutional investors. Learn more on BLTE's institutional investor holdings.

Which institutional investors have been buying Belite Bio stock?

The following institutional investors have purchased Belite Bio stock in the last 24 months: Atria Wealth Solutions Inc. ($760.29K), Armistice Capital LLC ($184K), JPMorgan Chase & Co. ($6.27K), XTX Topco Ltd ($5.39K), Jump Financial LLC ($5.20K), State Street Corp ($4.42K), and GAMMA Investing LLC ($862.00).

How much institutional buying is happening at Belite Bio?

Institutional investors have bought a total of 966,432 shares in the last 24 months. This purchase volume represents approximately $32.32M in transactions.

Which Belite Bio major shareholders have been selling company stock?

The following institutional investors have sold Belite Bio stock in the last 24 months: Atria Wealth Solutions Inc. ($740.48K), and Point72 Asset Management L.P. ($3.90K).

How much institutional selling is happening at Belite Bio?

Institutional investors have sold a total of 744,379 shares in the last 24 months. This volume of shares sold represents approximately $23.77M in transactions.



This page (NASDAQ:BLTE) was last updated on 1/15/2025 by MarketBeat.com Staff
From Our Partners